October 2018

FDA proposes international standardization for generic drug development and approval

In the US, prescription drug prices are continuing to increase. In response to this, the FDA has come up with new initiatives to improve generic drug development and access. Generic drugs are cheaper alternatives to [...]

By WEP|2021-03-15T11:06:45+00:00October 31st, 2018|FDA, Reference Listed Drug|

MHRA publishes proposals for dealing with a no-deal Brexit

In the last remaining months leading up to the UK’s exit from the EU, the Medicines and Healthcare products Regulatory Agency (MHRA) is taking action to prepare for a potential ‘no-deal’ Brexit. The MHRA strongly [...]

By WEP|2021-03-15T11:06:48+00:00October 9th, 2018|Governments, Health|